NEUROECTODERMAL TUMORS, PRIMITIVE
Clinical trials for NEUROECTODERMAL TUMORS, PRIMITIVE explained in plain language.
Never miss a new study
Get alerted when new NEUROECTODERMAL TUMORS, PRIMITIVE trials appear
Sign up with your email to follow new studies for NEUROECTODERMAL TUMORS, PRIMITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes on brain tumors: first human trial begins
Disease control Recruiting nowThis early-phase study tests an oral drug called ONC206 in 102 adults with brain tumors that have come back or are rare. The main goal is to find the safest dose and understand side effects. Participants take the drug by mouth on a weekly schedule, and researchers monitor for any…
Matched conditions: NEUROECTODERMAL TUMORS, PRIMITIVE
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
Virus therapy takes on childhood brain cancer
Disease control Recruiting nowThis early-stage trial tests a specially engineered virus, G207, in children and young adults (ages 3 to 21) whose cerebellar brain tumors have come back or not responded to standard treatments. The virus is injected directly into the tumor, and a single low dose of radiation is …
Matched conditions: NEUROECTODERMAL TUMORS, PRIMITIVE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:05 UTC